[Federal Register: February 8, 2008 (Volume 73, Number 27)]
[Notices]
[Page 7560-7561]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08fe08-53]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-1771, CMS-10145 and CMS-10204]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS) is publishing the following summary of proposed
collections for public comment. Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
1. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Attending
Physicians Statement and Documentation of Medicare Emergency and
Supporting Regulations in 42 CFR 424.103; Use: 42 CFR 424.103(b)
requires that before a nonparticipating hospital may be paid for
emergency services rendered to a Medicare beneficiary, a statement must
be submitted that is sufficiently comprehensive to support that an
emergency existed. Form CMS-1771 contains a series of questions
relating to the medical necessity of the emergency. The attending
physician must attest that the hospitalization was required under the
regulatory emergency definition (42 CFR 424.101) and give clinical
documentation to support the claim. Form Number: CMS-1771 (OMB
0938-0023); Frequency: Yearly; Affected Public: Private sector--
business or other for-profit and not-for-profit institutions; Number of
Respondents: 100; Total Annual Responses: 200; Total Annual Hours: 50.
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare Part B
Drug and Biological Competitive Acquisition Program and Supporting
Regulations in 42 CFR Sections 414.906, 414.908, 414.910, 414.914,
414.916, and 414.917; Use: Section 303(d) of the Medicare Prescription
Drug, Improvement, and Modernization Act of 2003 (MMA) provides an
alternative
[[Page 7561]]
payment methodology for Part B covered drugs that are not paid on a
cost or prospective payment basis. In particular, section 303(d) of the
MMA amends Title XVIII of the Social Security Act by adding a new
section 1847(B), which establishes a competitive acquisition program
for the acquisition of and payment for Part B covered drugs and
biologicals furnished on or after January 1, 2006. Since its inception,
additional legislation has augmented the CAP. Section 108 of the
Medicare Improvements and Extension Act under Division B, Title I of
the Tax Relief Health Care Act of 2006 (MIEA-TRHCA) amended section
1847b(a)(3) of the Social Security Act and requires that CAP implement
a post payment review process. This procedure is done to assure that
payment is made for a drug or biological under this section only if the
drug or biological has been administered to a beneficiary. Form Number:
CMS-10145 (OMB 0938-0945); Frequency: Weekly; Affected Public:
Private sector--business or other for-profit and not-for-profit
institutions; Number of Respondents: 3,000; Total Annual Responses:
156,000; Total Annual Hours: 31,188.
3. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Evaluation of the
Medical Adult Day Care Services Demonstration; Use: Section 703 of the
Medicare Prescription Drug, Improvement and Modernization Act of 2003
(Pub. L. 108-173) authorizes a three-year demonstration to conduct an
evaluation of the clinical and cost-effectiveness of providing medical
adult day-care services as a substitute for a portion of home health
services that would otherwise be provided in the beneficiary's home.
Delivering home health services in the adult day-care setting
represents an expansion of coverage under the home health benefit under
Medicare. The Demonstration aims to evaluate both the costs and the
benefits of delivering home health services in the adult day-care
setting. The evaluation will examine the achievements as well as the
difficulties inherent in demonstration implementation.
Telephone survey data from Medicare beneficiary's interviews are to
be completed during Phase II of the Evaluation of the Medical Adult
Day-Care Services Demonstration. The survey was developed based on
collection of data from face-to-face interviews with beneficiaries from
Phase I of the Demonstration evaluation. Form Number: CMS-10204
(OMB 0938-1017); Frequency: Once; Affected Public: Individuals
or households; Number of Respondents: 900; Total Annual Responses: 900;
Total Annual Hours: 150.
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web Site address at http://www.cms.hhs.gov/PaperworkReductionActof1995,
or E-mail your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call
the Reports Clearance Office on (410) 786-1326.
In commenting on the proposed information collections please
reference the document identifier or OMB control number. To be assured
consideration, comments and recommendations must be submitted in one of
the following ways by April 8, 2008.
1. Electronically. You may submit your comments electronically to
http://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) accepting comments.
2. By regular mail. You may mail written comments to the following
address:
CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number---- , Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
Dated: January 30, 2008.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. E8-2064 Filed 2-7-08; 8:45 am]
BILLING CODE 4120-01-P